Chronic Diseases Value, Affordability, and… Understanding the Full Value of Long-Acting Therapies: less is more? Read more
Health Technology Assessment… Value, Affordability, and… An Analysis of NICE’s Optimised Decisions from 2015 to 2024 Read more
Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more
Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more
Drug Development/R&D Economics of Innovation Competition The Importance of Diversity of Supply in Rare Diseases Markets Read more © VK Studio at stock.adobe.com
Back Bulletin April 2023 Advancing HTA through collaboration Read more Bulletin March 2023 If equality could go viral Read more Bulletin February 2023 Special Edition: Innovation Policy Prize Read more Bulletin January 2023 Building a resilient and sustainable healthcare in 2023 Read more